Revenues and Net Profit Consolidated FS Q1/2019 Q1/2020 Change MB. % MB. % MB. % Revenue from contracts with customers 89.9 16.3% 97.1 12.7% 7.1 7.9% Interest income and dividend income 336.4 60.9% 362.8
had total asset as of March 31, 2020 with amount of 817.41 million bath increase from December 31, 2019 by 6.50 million baht or 0.80% increased, the details of the change are as follows: 1.1 Current
assets as of December 31, 2019. A change in total assets of the Company and its subsidiary came from details as follow; Cash and cash equivalent increased by 12.33 million baht or 18.21% from December 31
financial statements for the three-month period ended 31 March 2019 and 2020 Revenues Q1/20 Q1/19 Change +/(-) Revenue from hotel operations 232 367 (36.9) Revenue from property development operations 238 115
., BANGKAE, BANGKAE, BANGKOK, THAILAND. 10160 Tel: 02-455-2888 Fax: 02-455-2763 (“TRANSLATION”) TG 080/63 August 7, 2020 Subject: Clarification of the Operating Result for the significant change Attention: The
million or 4.51 percent. Such change was mainly because of the decrease in short-term loans from related companies, the increase in short-term loans from financial institutions, and the recognition of
Change DOD BIOTECH PUBLIC COMPANY LIMITED เลขท ี111 หมู่ท ี2 ตําบลท่าจีน อําเภอเมืองสมุทรสาคร จังหวดัสมุทรสาคร 74000 111 Moo 2 TambonThachin, Amphurmuangsamutsakhon, Samutsakhon 74000 As of March 31, 2020
performance of the Company three-month for the Quarter 1/2020 ended 31 March 2020 are as follows: change Q1/2020 Q1/2019 increase (decrease) Sales 224.5 213.9 5.0% Other income 1.9 10.8 -82.3% Cost of sales
second quarter ended June 30, 2020 which the details are as follows: Unit: million Baht For 3-month period (Apr-Jun) 2020 2019 Change % Increase (Decrease) Revenue from sale of goods 128.52 164.02 (35.50
months ended 30th June 2019 Change THB million % THB million % THB million % Sales of electricity 175.94 100.00 85.70 100.00 90.25 105.31 Cost of goods sold (77.17) -43.86 (36.95) -43.12 (40.22) 108.84